Is a complete BME/FAE research report available?

Question

Accepted Answer

No complete published report is available for bme/FAE (BME/FAE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	1.4B
Revenue (ttm)	711.1M
Net income (ttm)	84.2M
EPS (ttm)	€0.27
Shares out	311.3M
P/E (trailing)	17.0x
P/E (forward)	14.2x
Dividend	€0.18 (3.93%)
Volume	181,216

Metric	Value
Country	Spain
Country code	ES
Employees	2,681
Employees Change	905%
Employees Change Percent	50.96
Enterprise value	EUR 1.7B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	21.16
Industry PE Fwd	18.95
Isin	ES0134950F36
Last refreshed	2026-08-02
Market cap	EUR 1.4B
Price	EUR 4.56
Price currency	EUR
Rev Per Employee	265,418.81x
Sector	Healthcare
Sector PE	20.27
Sector PE Fwd	13.48
Sic	2834
Symbol	bme/FAE
Website	https://faesfarma.com

Metric	Value
Earnings Yield	5.93%
EV Earnings	20.12x
EV/EBIT	61.55x
EV/EBITDA	26.13x
EV/FCF	27.08x
EV/Sales	2.38x
FCF yield	4.41%
Forward P/E	14.19x
P/B ratio	1.83x
P/E ratio	17.01x
P/S ratio	2x
PE Ratio10 Y	15.41x
PE Ratio3 Y	13.13x
PE Ratio5 Y	12.75x
PEG ratio	0.81x

Metric	Value
EBIT Margin	3.78%
EBITDA Margin	8.9%
FCF margin	8.79%
Gross margin	65.17%
Gross Profit	EUR 463.4M
Gross Profit Growth	31.69%
Gross Profit Growth Q	28.79%
Gross Profit Growth3 Y	14.51%
Gross Profit Growth5 Y	12.56%
Net Income	EUR 84.2M
Net Income Growth	-20.09%
Net Income Growth Q	8.94%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-2.05%
Net Income Growth5 Y	2.65%
Pretax Margin	12.74%
Profit Margin	11.84%
Profit Per Employee	EUR 31,422
Profitable Quarters	EUR 57
Profitable Years	23
ROA	5.03
Roa5y	8.22
ROCE	2.21
ROE	11.22
Roe5y	14.66
ROIC	8.73
Roic5y	15.61

Metric	Value
Cagr10y	6.24%
Cagr15y	10.3%
Cagr1y	6.78%
Cagr20y	2.05%
Cagr3y	16.13%
Cagr5y	10.83%
Div CAGR10	3.47%
Div CAGR3	-11.18%
Div CAGR5	-8.26%
EPS Growth	-20.45
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-2.63
EPS Growth5 Y	1.6
FCF Growth	-20.26%
FCF Growth5 Y	15.3%
OCF Growth	-20.55%
OCF Growth10 Y	7.16%
OCF Growth3 Y	-6.26%
OCF Growth5 Y	7.39%
Revenue Growth	30.76x
Revenue Growth Q	23.96x
Revenue Growth Quarters	10x
Revenue Growth Years	13x
Revenue Growth3 Y	14.91x
Revenue Growth5 Y	12.3x

BME/FAE (BME/FAE)

Coverage state: Market snapshot only — no published research

Generate the first BME/FAE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BME/FAE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BME/FAE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BME/FAE

Frequently asked questions

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 1.4B
Cash	EUR 123.7M
Current Assets	EUR 523.7M
Current Liabilities	EUR 198.8M
Debt	EUR 396.9M
Debt EBITDA	EUR 6.12
Debt Equity	EUR 0.51
Debt FCF	EUR 6.35
Equity	EUR 775.4M
Interest Coverage	2.82
Liabilities	EUR 666.6M
Long Term Assets	EUR 918.3M
Long Term Liabilities	EUR 467.7M
Net Cash	EUR -273.2M
Net Cash By Market Cap	EUR -19.25
Net Debt EBITDA	EUR 4.21
Net Debt Equity	EUR 0.35
Net Debt FCF	EUR 4.37
Tangible Book Value	EUR 252.4M
WACC	5.29

Metric	Value
Current ratio	2.63
Inventory Turnover	1.42
Net Working Capital	EUR 236.6M
Quick ratio	1.6
Working Capital	EUR 324.8M
Working Capital Turnover	EUR 2.52

Metric	Value
Buyback Yield	-0.51%
Dividend Growth	-28.49%
Dividend Growth Years	1%
Dividend per share	EUR 0.18
Dividend Years	38
Dividend Yield	3.93%
Ex Div Date	2026-07-02
Last Dividend	EUR 0.07
Payout Frequency	Semi-Annual
Payout Ratio	66.19%

Metric	Value
10Y total return	83.17%
1Y total return	6.77%
200-day SMA	4.76
3Y total return	56.62%
50-day SMA	4.55
50-day SMA vs 200-day SMA	50under200
5Y total return	67.17%
All Time High	11.58
All Time High Change	-60.62%
All Time High Date	2007-04-11
All Time Low	0.47
All Time Low Change	863.86%
All Time Low Date	1992-09-22
ATR	0.1
Beta	0.34
Beta1y	0.93
Beta2y	0.66
Ch YTD	-11.63
High	4.59
High52	5.44
High52 Date	2026-01-07
High52ch	-16.18%
Low	4.49
Low52	4.1
Low52 Date	2025-09-02
Low52ch	11.22%
Ma50ch	0.15%
Price vs 200-day SMA	-4.28%
RSI	52.56
RSI Monthly	55.29
RSI Weekly	46.61
Sharpe ratio	0.32x
Sortino ratio	0.77
Total Return	3.44%
Tr YTD	-9.68
Tr15y	335.19%
Tr1m	0.91%
Tr1w	-0.11%
Tr3m	-4.6%

Metric	Value
Analyst Count	4
Analyst Ratings	Buy
Operating Income	EUR 98.2M
Operating Income Growth	-3.43
Operating Income Growth Q	16.08
Operating Income Growth3 Y	-1.3
Operating Income Growth5 Y	2.46
Operating margin	13.81
Price target	EUR 5.36
Price Target Change	EUR 17.54

Metric	Value
Float	217,058,130%
Net Borrowing	237,438,000
Shares Insiders	2.18%
Shares Institutions	8.25%
Shares Out	311,261,239
Shares Yo Y	0.51%

Metric	Value
Adjusted FCF	EUR 61.8M
Adjusted OCF	79,611,000
Average Volume	119,788.15x
CAPEX	EUR -17.8M
Ch10y	29.18
Ch15y	170.5
Ch1m	-0.65
Ch1w	-0.11
Ch1y	4.47
Ch20y	-13.78
Ch3m	-6.08
Ch3y	42.72
Ch5y	38.6
Ch6m	-12.81
Change	0.66%
Change From Open	0.66
Close	4.53
Days Gap	0
Depreciation Amortization	25,506,500
Dollar Volume	826,345
Earnings Date	2026-07-30
EBIT	EUR 27.5M
EBITDA	EUR 64.8M
EPS	EUR 0.27
F Score	5
FCF	EUR 62.5M
FCF EV Yield	3.69x
FCF Per Share	EUR 0.2
Financing CF	182,021,000
Fiscal Year End	December
Founded	1,933
Income Tax	EUR 6.1M
Investing CF	-242,049,000
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Last Split Date	2015-04-07
Last Split Type	Forward
Lynch Fair Value	EUR 1.34
Lynch Upside	-70.6
Ma150	4.8
Ma150ch	-4.92%
Ma20	4.49
Ma20ch	1.51%
Net CF	20,329,000
Open	4.53
P FCF Ratio	22.7
P FCF Ratio SBC	22.97
P OCF Ratio	17.66
P OCF Ratio SBC	17.83
Payment Date	2026-07-06
Position In Range	71.43
Ppne	347,243,000
Price Date	2026-07-31
Price EBITDA	EUR 21.9
Ptbv Ratio	5.62
Relative Volume	1.58x
Revenue	711,057,000x
SBC By Revenue	0.1x
Share Based Comp	746,000
Tax By Revenue	0.86x
Tax Rate	6.77%
Tr20y	49.94%
Tr6m	-11.44%
Volume	181,216